Purpose of review
To provide an update on animal models of antineutrophil cytoplasmic autoantibody (ANCA)-mediated vasculitis and highlight recent insights gained from studies in these models pertaining to immunopathogenesis.
Animal models support the pathogenic potential of myeloperoxidase (MPO)-ANCA. Alternative pathway complement activation has been identified as a novel inflammatory pathway in disease induction and a potential target for intervention. Interventions targeting B cells, antibodies, and signal transduction pathways may hold promise as well. The role of T cells is beginning to be explored, and studies indicate a prominent role for Th17 responses. The link between infection and ANCA vasculitis is well established. In animal models, Toll-like receptor (TLR)4 ligation is involved in disease induction. Ligation of TLRs contributes to the initiation of anti-MPO autoimmune responses in which TLR2 activation induces a Th17 response and TLR9 activation directs a Th1 response. An animal model for PR3-ANCA vasculitis is not available yet but models with a humanized immune system are being developed and show promising first results.
Animal models of MPO-ANCA vasculitis have contributed substantially to our understanding of disease immunopathogenesis and have illuminated novel targets for intervention. The development of PR3-ANCA animal models remains a challenge but recent observations in humanized model systems offer hope.
|Number of pages||7|
|Journal||CURRENT OPINION IN RHEUMATOLOGY|
|Publication status||Published - Jan-2012|
- animal models
- antineutrophil cytoplasmic autoantibodies
- ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
- IGG GLYCAN HYDROLYSIS
- INTERACTIONS IN-VIVO
- ANTIMYELOPEROXIDASE ANTIBODIES
- MEDIATED GLOMERULONEPHRITIS
- HUMAN NEUTROPHILS
- TH17 CELLS